The refractive outcome of Toric Lentis Mplus implant in cataract surgery.
OBJECTIVE
To evaluate the refractive outcome of Toric Lentis Mplus intraocular lens (IOL) implant.


METHODS
This is a retrospective case series. Consecutive patients with corneal astigmatism of at least 1.5 D had Toric Lentis Mplus IOL implant during cataract surgery. The exclusion criteria included irregular astigmatism on corneal topography, large scotopic pupil diameter (>6 mm), poor visual potential and significant ocular comorbidity. Postoperative manifest refraction, uncorrected distance visual acuity (UDVA), best-corrected distance visual acuity (BCVA), uncorrected intermediate visual acuity (UIVA) at 3/4 m and uncorrected near visual acuity (UNVA) were obtained.


RESULTS
There were 70 eyes from 49 patients in this study. Patients were refracted at a median of 8.9wk (range 4.0 to 15.5) from the operation date. Sixty-five percent of eyes had 6/7.5 (0.10 logMAR) or better, and 99% 6/12 (0.30 logMAR) or better postoperative UDVA. Eighty-nine percent could read Jaeger (J) 3 (0.28 logMAR) and 95% J5 (0.37 logMAR) at 40 cm. The median magnitude of astigmatism decreased from 1.91 D to 0.49 D (Wilcoxon, P<0.001) after the operation. The range of the cylindrical error was reduced from 1.5-3.95 D (keratometric) preoperatively to 0.00-1.46 D (subjective refraction transposed to corneal plane) postoperatively.


CONCLUSIONS
Toric Lentis Mplus IOL has good predictability in reducing preexisting corneal astigmatism.
Birmingham and Midland Eye Centre, City Hospital, Birmingham BH18 7QH, United Kingdom.
Patrick J
PJ
Chiam
Optegra Manchester Eye Hospital, Manchester M20 2EY, United Kingdom.
Say A
SA
Quah
Toric Lentis Mplus; multi-focal intraocular lens implant; refractive outcome